Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P.D. Nathan
Adjuvant Bevacizumab for Melanoma Patients at High Risk of Recurrence: Survival Analysis of the AVAST-M Trial
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Cancers
Cancer Research
Oncology
Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Clinical Cancer Research
Cancer Research
Oncology
Adjuvant Chemotherapy Improves Survival of Patients With High-Risk Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Matched Analysis
BMC Urology
Medicine
Reproductive Medicine
Urology
Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Specialized Surveillance for Individuals at High Risk for Melanoma
JAMA Dermatology
Dermatology
Medicine
Survival Analysis of Risk Factors for Major Recurrence of Intracranial Aneurysms After Coiling
Canadian Journal of Neurological Sciences
Medicine
Neurology
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Clinical Cancer Research
Cancer Research
Oncology
A Phase III Study (CheckMate 238) of Adjuvant Immunotherapy With Nivolumab (NIVO) Versus Ipilimumab (IPI) After Complete Resection of Stage IIIb/c or Stage IV Melanoma (MEL) in Patients (Pts) at High Risk for Recurrence
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
